<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Drug Policy</journal-id><journal-id journal-id-type="iso-abbrev">Int J Drug Policy</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>The International journal on drug policy</journal-title></journal-title-group><issn pub-type="ppub">0955-3959</issn><issn pub-type="epub">1873-4758</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10683765</article-id><article-id pub-id-type="pmcid-ver">PMC10683765.1</article-id><article-id pub-id-type="pmcaid">10683765</article-id><article-id pub-id-type="pmcaiid">10683765</article-id><article-id pub-id-type="manuscript-id">NIHMS1892231</article-id><article-id pub-id-type="pmid">37060885</article-id><article-id pub-id-type="doi">10.1016/j.drugpo.2023.104018</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1892231</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1892231</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>RE-INCARCERATION AND ASSOCIATED SOCIAL, STRUCTURAL AND BEHAVIOURAL FACTORS AMONG PEOPLE WHO USE DRUGS IN AN URBAN CANADIAN SETTING</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Brooks</surname><given-names initials="O">Olivia</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hayashi</surname><given-names initials="K">Kanna</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cui</surname><given-names initials="Z">Zishan</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Milloy</surname><given-names initials="MJ">M-J</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kerr</surname><given-names initials="T">Thomas</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fairbairn</surname><given-names initials="N">Nadia</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>British Columbia Centre on Substance Use, Vancouver, Canada</aff><aff id="A2"><label>2</label>Department of Medicine, University of British Columbia, Vancouver, BC, Canada</aff><aff id="A3"><label>3</label>Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada</aff><author-notes><corresp id="CR1"><bold>Send correspondence to:</bold> Nadia Fairbairn, Assistant Professor, Division of Social Medicine, Department of Medicine, University of British Columbia, 400-1045 Howe Street, Vancouver BC V6Z 2A9 Canada, <email>bccsu-nf@bccsu.ubc.ca</email></corresp><fn fn-type="COI-statement" id="FN2"><p id="P33">Declaration of interests</p><p id="P34">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></fn><fn fn-type="COI-statement" id="FN4"><p id="P39">Potential conflict of interest</p><p id="P40">All authors declare no conflict of interest.</p></fn></author-notes><pub-date pub-type="ppub"><month>5</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>13</day><month>4</month><year>2023</year></pub-date><volume>115</volume><issue-id pub-id-type="pmc-issue-id">449882</issue-id><fpage>104018</fpage><lpage>104018</lpage><pub-history><event event-type="nihms-submitted"><date><day>22</day><month>11</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>01</day><month>05</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>05</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 16:25:15.287"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1892231.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P1">People who use drugs (PWUD) are disproportionately incarcerated, however little is known about specific substance use, social and structural factors associated with re-incarceration among PWUD. We aimed to identify the socio-structural and substance use factors associated with re-incarceration among structurally-marginalized PWUD.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">We used longitudinal data from two prospective cohorts of PWUD in Vancouver, Canada. We included adults reporting at least one incarceration event in the last six months and who completed at least one additional follow-up study visit. We performed multivariable extended Cox regression to explore factors associated with re-incarceration.</p></sec><sec id="S3"><title>Results:</title><p id="P3">Among 468 eligible participants, the median age was 40 years (Q1-Q3 = 34&#8211;46 years), 346 (73.9%) were men, 177 (37.8%) identified as Indigenous, and 227 (48.5%) experienced at least one re-incarceration event. Incidence rate of re-incarceration was 157 incarceration events per 1000 person years. In multivariable analyses, homelessness (adjusted hazard ratio [AHR] = 2.17; 95% confidence interval [95% CI]: 1.79&#8211;2.61), community judicial supervision (AHR = 3.89; 95% CI: 3.21&#8211;4.71) and re-incarceration during the study period (once: AHR = 1.95, 95% CI: 1.55&#8211;2.44; two or more events: AHR = 1.53, 95% CI: 1.23&#8211;1.90) were positively associated with re-incarceration. Among substance use variables that included illicit drugs, only heavy alcohol use remained significantly associated with re-incarceration across analyses after adjustment (AHR = 1.32; 95% CI: 1.06&#8211;1.65). Engagement in addiction treatment (AHR = 0.63; 95% CI: 0.53&#8211;0.75), mental illness (AHR = 0.70; 95% CI: 0.59&#8211;0.84) and age (AHR = 0.96; 95% CI: 0.95&#8211;0.97) were negatively associated with re-incarceration.</p></sec><sec id="S4"><title>Conclusion:</title><p id="P4">Access to housing and substance use services, including treatment for alcohol use disorder, following incarceration may reduce re-incarceration among PWUD. The high rates of re-incarceration of PWUD in our sample underscores how structural factors&#8212;such as homelessness and criminalization of substance use&#8212;drive re-incarceration among PWUD.</p></sec></abstract><kwd-group><kwd>re-incarceration</kwd><kwd>recidivism</kwd><kwd>people who use drugs</kwd><kwd>homelessness</kwd><kwd>heavy alcohol use</kwd><kwd>jail</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>